Bioorthogonal chemistry: Bridging chemistry, biology, and medicine.


Journal

Chem
ISSN: 2451-9294
Titre abrégé: Chem
Pays: United States
ID NLM: 101688902

Informations de publication

Date de publication:
10 Aug 2023
Historique:
pmc-release: 10 08 2024
medline: 15 7 2024
pubmed: 15 7 2024
entrez: 15 7 2024
Statut: ppublish

Résumé

As chemical biologists sought methods to modify and study biomolecules in their native environments, the need for bioorthogonal chemical reactions emerged. These fast and selective reactions between otherwise inert, abiotic functional groups have enabled exploration of some of the most intriguing and challenging questions in chemical biology. Further, the ability to perform organic reactions in cells and organisms has led to important applications in clinical spaces, and one reaction is now an integral part of a phase 2 trial for treating solid tumors. Given that bioorthogonal chemistry was a recipient of the 2022 Nobel Prize, we expect this field to be even more energized. Here, we highlight some of the most recent studies in this sphere and how these set the stage for where bioorthogonal chemistry is headed.

Identifiants

pubmed: 39006002
doi: 10.1016/j.chempr.2023.05.016
pmc: PMC11245302
doi:

Types de publication

Journal Article

Langues

eng

Pagination

2095-2109

Déclaration de conflit d'intérêts

DECLARATION OF INTERESTS The authors declare no competing interests.

Auteurs

Kaitlin M Hartung (KM)

Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Ellen M Sletten (EM)

Department of Chemistry and Biochemistry, University of California, Los Angeles, Los Angeles, CA 90095, USA.

Classifications MeSH